444 related articles for article (PubMed ID: 12540195)
1. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9).
Van den Steen PE; Dubois B; Nelissen I; Rudd PM; Dwek RA; Opdenakker G
Crit Rev Biochem Mol Biol; 2002 Dec; 37(6):375-536. PubMed ID: 12540195
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
3. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
4. On the roles of extracellular matrix remodeling by gelatinase B.
Opdenakker G
Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
[TBL] [Abstract][Full Text] [Related]
5. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
6. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
7. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Dubois B; Opdenakker G; Carton H
Acta Neurol Belg; 1999 Mar; 99(1):53-6. PubMed ID: 10218093
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
10. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H
Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
[TBL] [Abstract][Full Text] [Related]
12. Human endothelial gelatinases and angiogenesis.
Nguyen M; Arkell J; Jackson CJ
Int J Biochem Cell Biol; 2001 Oct; 33(10):960-70. PubMed ID: 11470230
[TBL] [Abstract][Full Text] [Related]
13. Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
Warner RL; Beltran L; Younkin EM; Lewis CS; Weiss SJ; Varani J; Johnson KJ
Am J Respir Cell Mol Biol; 2001 May; 24(5):537-44. PubMed ID: 11350822
[TBL] [Abstract][Full Text] [Related]
14. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
15. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity.
Sasaki M; Kashima M; Ito T; Watanabe A; Sano M; Kagaya M; Shioya T; Miura M
Mediators Inflamm; 2000; 9(2):85-91. PubMed ID: 10958381
[TBL] [Abstract][Full Text] [Related]
16. Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies.
St-Pierre Y; Van Themsche C; Estève PO
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):206-15. PubMed ID: 14561155
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
18. In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes.
Descamps FJ; Martens E; Ballaux F; Geboes K; Opdenakker G
J Pathol; 2004 Dec; 204(5):555-61. PubMed ID: 15538738
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
[TBL] [Abstract][Full Text] [Related]
20. Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A.
Higashi S; Miyazaki K
Biochemistry; 2003 Jun; 42(21):6514-26. PubMed ID: 12767235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
